Prognostic variables in node-negative and node-positive breast cancer [electronic resource] /
Prognostic variables in node-negative and node-positive breast cancer — Introduction -- Routinely available indicators of prognosis in breast cancer -- Prognostic factors for patients with breast cancers 1cm and smaller -- Steroid hormone receptors in breast cancer management -- S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer -- S-phase fraction and breast cancer — a decade of experience -- Prognostic and predictive value of thymidine labelling index in breast cancer -- Cyclin D1 in breast cancer -- Cyclins and breast cancer -- Prognostic implications of expression of the cell cycle inhibitor p27Kip1 -- The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer -- c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients -- HER-2/neu as a predictive marker of response to breast cancer therapy -- Prognostic and predictive value of p53 and p21 in breast cancer -- The urokinase plasminogen activator system as a target for prognostic studies in breast cancer -- Metalloproteinases and tissue inhibitors of metalloproteinases -- Matrix metalloproteinase inhibitors -- The 67 kDa laminin receptor as a prognostic factor in human cancer -- Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis -- Clinical significance of angiogenic factors in breast cancer -- Insulin-like growth factors in human breast cancer -- Molecular prognostic markers in breast cancer -- Prognostic significance of micrometastatic bone marrow involvement -- Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis -- Time-dependence of hazard ratios for prognostic factors in primary breast cancer -- Circulating tumor markers in breast cancer: Accepted utilities and novel prospects -- The relationship between prognostic and predictive factors in the management of breast cancer -- Methodological challenges in the evaluation of prognostic factors in breast cancer -- Assessing the clinical impact of prognostic factors: When is “statistically significant” clinically useful? -- Prognostic variables in node-negative and node-positive breast cancer — editorial -- Author index.
Main Authors: | , |
---|---|
Format: | Texto biblioteca |
Language: | eng |
Published: |
Boston, MA : Springer US : Imprint: Springer,
1998
|
Subjects: | Medicine., Oncology., Medicine & Public Health., |
Online Access: | http://dx.doi.org/10.1007/978-1-4615-5195-9 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
KOHA-OAI-TEST:178854 |
---|---|
record_format |
koha |
spelling |
KOHA-OAI-TEST:1788542018-07-30T22:58:29ZPrognostic variables in node-negative and node-positive breast cancer [electronic resource] / Gasparini, Giampietro. editor. SpringerLink (Online service) textBoston, MA : Springer US : Imprint: Springer,1998.engPrognostic variables in node-negative and node-positive breast cancer — Introduction -- Routinely available indicators of prognosis in breast cancer -- Prognostic factors for patients with breast cancers 1cm and smaller -- Steroid hormone receptors in breast cancer management -- S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer -- S-phase fraction and breast cancer — a decade of experience -- Prognostic and predictive value of thymidine labelling index in breast cancer -- Cyclin D1 in breast cancer -- Cyclins and breast cancer -- Prognostic implications of expression of the cell cycle inhibitor p27Kip1 -- The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer -- c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients -- HER-2/neu as a predictive marker of response to breast cancer therapy -- Prognostic and predictive value of p53 and p21 in breast cancer -- The urokinase plasminogen activator system as a target for prognostic studies in breast cancer -- Metalloproteinases and tissue inhibitors of metalloproteinases -- Matrix metalloproteinase inhibitors -- The 67 kDa laminin receptor as a prognostic factor in human cancer -- Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis -- Clinical significance of angiogenic factors in breast cancer -- Insulin-like growth factors in human breast cancer -- Molecular prognostic markers in breast cancer -- Prognostic significance of micrometastatic bone marrow involvement -- Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis -- Time-dependence of hazard ratios for prognostic factors in primary breast cancer -- Circulating tumor markers in breast cancer: Accepted utilities and novel prospects -- The relationship between prognostic and predictive factors in the management of breast cancer -- Methodological challenges in the evaluation of prognostic factors in breast cancer -- Assessing the clinical impact of prognostic factors: When is “statistically significant” clinically useful? -- Prognostic variables in node-negative and node-positive breast cancer — editorial -- Author index.Medicine.Oncology.Medicine & Public Health.Oncology.Springer eBookshttp://dx.doi.org/10.1007/978-1-4615-5195-9URN:ISBN:9781461551959 |
institution |
COLPOS |
collection |
Koha |
country |
México |
countrycode |
MX |
component |
Bibliográfico |
access |
En linea En linea |
databasecode |
cat-colpos |
tag |
biblioteca |
region |
America del Norte |
libraryname |
Departamento de documentación y biblioteca de COLPOS |
language |
eng |
topic |
Medicine. Oncology. Medicine & Public Health. Oncology. Medicine. Oncology. Medicine & Public Health. Oncology. |
spellingShingle |
Medicine. Oncology. Medicine & Public Health. Oncology. Medicine. Oncology. Medicine & Public Health. Oncology. Gasparini, Giampietro. editor. SpringerLink (Online service) Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
description |
Prognostic variables in node-negative and node-positive breast cancer — Introduction -- Routinely available indicators of prognosis in breast cancer -- Prognostic factors for patients with breast cancers 1cm and smaller -- Steroid hormone receptors in breast cancer management -- S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen-receptor-positive breast cancer -- S-phase fraction and breast cancer — a decade of experience -- Prognostic and predictive value of thymidine labelling index in breast cancer -- Cyclin D1 in breast cancer -- Cyclins and breast cancer -- Prognostic implications of expression of the cell cycle inhibitor p27Kip1 -- The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer -- c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients -- HER-2/neu as a predictive marker of response to breast cancer therapy -- Prognostic and predictive value of p53 and p21 in breast cancer -- The urokinase plasminogen activator system as a target for prognostic studies in breast cancer -- Metalloproteinases and tissue inhibitors of metalloproteinases -- Matrix metalloproteinase inhibitors -- The 67 kDa laminin receptor as a prognostic factor in human cancer -- Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis -- Clinical significance of angiogenic factors in breast cancer -- Insulin-like growth factors in human breast cancer -- Molecular prognostic markers in breast cancer -- Prognostic significance of micrometastatic bone marrow involvement -- Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis -- Time-dependence of hazard ratios for prognostic factors in primary breast cancer -- Circulating tumor markers in breast cancer: Accepted utilities and novel prospects -- The relationship between prognostic and predictive factors in the management of breast cancer -- Methodological challenges in the evaluation of prognostic factors in breast cancer -- Assessing the clinical impact of prognostic factors: When is “statistically significant” clinically useful? -- Prognostic variables in node-negative and node-positive breast cancer — editorial -- Author index. |
format |
Texto |
topic_facet |
Medicine. Oncology. Medicine & Public Health. Oncology. |
author |
Gasparini, Giampietro. editor. SpringerLink (Online service) |
author_facet |
Gasparini, Giampietro. editor. SpringerLink (Online service) |
author_sort |
Gasparini, Giampietro. editor. |
title |
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
title_short |
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
title_full |
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
title_fullStr |
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
title_full_unstemmed |
Prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
title_sort |
prognostic variables in node-negative and node-positive breast cancer [electronic resource] / |
publisher |
Boston, MA : Springer US : Imprint: Springer, |
publishDate |
1998 |
url |
http://dx.doi.org/10.1007/978-1-4615-5195-9 |
work_keys_str_mv |
AT gasparinigiampietroeditor prognosticvariablesinnodenegativeandnodepositivebreastcancerelectronicresource AT springerlinkonlineservice prognosticvariablesinnodenegativeandnodepositivebreastcancerelectronicresource |
_version_ |
1756264468729298944 |